{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:29:33Z","timestamp":1789853373628,"version":"4.0.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2009\/09327-7"],"award-info":[{"award-number":["2009\/09327-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["142729\/2010-8"],"award-info":[{"award-number":["142729\/2010-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005942","name":"Butantan Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005942","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.vaccine.2014.02.029","type":"journal-article","created":{"date-parts":[[2014,3,2]],"date-time":"2014-03-02T16:15:27Z","timestamp":1393776927000},"page":"2829-2832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Rabies virus glycoprotein and immune response pattern using recombinant protein or recombinant RNA viral vectors"],"prefix":"10.1016","volume":"32","author":[{"given":"Renato M.","family":"Astray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella C.","family":"Ventini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera L.L.","family":"Boldorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda G.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra P.","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.02.029_bib0005","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/bit.24493","article-title":"Vaccine process technology","volume":"109","author":"Josefsberg","year":"2012","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2014.02.029_bib0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jbiotec.2012.08.012","article-title":"The future of human DNA vaccines","volume":"162","author":"Li","year":"2012","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2014.02.029_bib0015","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1016\/j.vaccine.2012.04.060","article-title":"RNA-based vaccines","volume":"30","author":"Ulmer","year":"2012","journal-title":"Vaccine"},{"issue":"11 (November)","key":"10.1016\/j.vaccine.2014.02.029_bib0020","doi-asserted-by":"crossref","first-page":"e1003001","DOI":"10.1371\/journal.ppat.1003001","article-title":"Vaccines. From empirical development to rational design","volume":"8","author":"Rueckert","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2014.02.029_bib0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nri3085","article-title":"Vaccines for the twenty-first century society","volume":"11","author":"Rappuoli","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2014.02.029_bib0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.virusres.2010.07.027","article-title":"Alphavirus vectors for cancer therapy","volume":"153","author":"Quetglas","year":"2010","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2014.02.029_bib0035","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biotechadv.2011.10.009","article-title":"Drosophila melanogaster S2 cells for expression of heterologous genes: from gene cloning to bioprocess development","volume":"30","author":"Moraes","year":"2012","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.vaccine.2014.02.029_bib0040","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jbiotec.2008.12.009","article-title":"High-level expression of rabies virus glycoprotein with the RNA-based Semliki Forest Virus expression vector","volume":"139","author":"Benmaamar","year":"2009","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2014.02.029_bib0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jbiotec.2009.07.003","article-title":"Rabies virus glycoprotein expression in Drosophila S2 cells. I. Design of expression\/selection vectors, subpopulations selection and influence of sodium butyrate and culture medium on protein expression","volume":"143","author":"Lemos","year":"2009","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2014.02.029_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jbiotec.2010.02.011","article-title":"Recombinant rabies virus glycoprotein synthesis in bioreactor by transfected Drosophila melanogaster S2 cells carrying a constitutive or an inducible promoter","volume":"146","author":"Ventini","year":"2010","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2014.02.029_bib0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/biot.200700179","article-title":"Analytical approach for extraction of recombinant membrane viral glycoprotein from stably transfected Drosophila melanogaster cells","volume":"3","author":"Astray","year":"2008","journal-title":"Biotechnol J"},{"key":"10.1016\/j.vaccine.2014.02.029_bib0060","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s10616-012-9522-6","article-title":"Kinetic studies of recombinant rabies virus glycoprotein (RVGP) cDNA transcription and mRNA translation in Drosophila melanogaster S2 cell populations","volume":"65","author":"Astray","year":"2013","journal-title":"Cytotechnology"},{"key":"10.1016\/j.vaccine.2014.02.029_bib0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10616-007-9060-9","article-title":"Improving heterologous protein expression in transfected Drosophila S2 cells as assessed by EGFP expression","volume":"54","author":"Santos","year":"2007","journal-title":"Cytotechnology"},{"key":"10.1016\/j.vaccine.2014.02.029_bib0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0168-1656(01)00362-5","article-title":"Higher production of rabies virus in serum-free medium cell cultures on microcarriers","volume":"92","author":"Frazzati-Gallina","year":"2001","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2014.02.029_bib0075","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/biot.200600211","article-title":"Rabies virus glycoprotein expression in Drosophila S2 cells I. Functional recombinant protein in stable co-transfected cell line","volume":"2","author":"Yokomizo","year":"2007","journal-title":"Biotechnol J"},{"key":"10.1016\/j.vaccine.2014.02.029_bib0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.coi.2011.03.006","article-title":"Viral vectors as vaccine platforms: deployment in sight","volume":"23","author":"Rollier","year":"2011","journal-title":"Curr Opin Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14002023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14002023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T22:53:35Z","timestamp":1565218415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14002023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":16,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0264410X14002023"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.02.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rabies virus glycoprotein and immune response pattern using recombinant protein or recombinant RNA viral vectors","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}